APA (7th ed.) Citation

Cassidy, J., Clarke, S., D&a#x00ED;az-Rubio, E., Scheithauer, W., Figer, A., Wong, R., . . . Díaz-Rubio, E. (2011). XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results. British Journal of Cancer, 105(1), 58. https://doi.org/10.1038/bjc.2011.201

Chicago Style (17th ed.) Citation

Cassidy, J., et al. "XELOX Vs FOLFOX-4 as First-line Therapy for Metastatic Colorectal Cancer: NO16966 Updated Results." British Journal of Cancer 105, no. 1 (2011): 58. https://doi.org/10.1038/bjc.2011.201.

MLA (9th ed.) Citation

Cassidy, J., et al. "XELOX Vs FOLFOX-4 as First-line Therapy for Metastatic Colorectal Cancer: NO16966 Updated Results." British Journal of Cancer, vol. 105, no. 1, 2011, p. 58, https://doi.org/10.1038/bjc.2011.201.